Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Whitlock

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Patents|May 15, 2015
Small-molecule anti-inflammatory drug compositions for the treatment of asthma: a patent review (2013 - 2014)Paul Glossop, Gavin Whitlock, Karl Gibson
Chemical Communications (Cambridge, England)|November 5, 2003
Stereoselective synthesis of tetrahydropyran-3-ones by rearrangement of oxonium ylides generated from metal carbenoidsJ Stephen Clark, Gavin Whitlock, Shende Jiang, et al.
Drug Discovery Today|July 30, 2009
Understanding CYP2D6 interactionsMarcel J de Groot, Florian Wakenhut, Gavin Whitlock, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2009
Pharmacological properties of 2-((R-5-chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a novel and selective alpha1A-adrenergic partial agonist, in in vitro and in vivo models of urethral functionKelly Conlon, Clare Christy, Simon Westbrook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2026
A novel potent and selective GCN2 inhibitor, APL-4098, has anti-leukemic activity through dysregulation of mitochondrial functionMonica Román-Trufero, Gavin Whitlock, Claire Seydoux, et al.
Basic Research in Cardiology|May 21, 2021
Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?Maaike Te Lintel Hekkert, Gary Newton, Kathryn Chapman, et al.
Journal of Medicinal Chemistry|February 28, 2013
Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platformBimbisar Desai, Karen Dixon, Elizabeth Farrant, et al.
ACS Infectious Diseases|March 14, 2022
The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease OutbreaksKirandeep Samby, Dominique Besson, Anirban Dutta, et al.
Cell Chemical Biology|March 28, 2026
Reshaping the progranulin/sortilin interaction for targeted degradation of extracellular proteinsCamilla Gustafsen, Joachim Vilstrup, Marianne Kristensen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|May 15, 2015
Small-molecule anti-inflammatory drug compositions for the treatment of asthma: a patent review (2013 - 2014)Paul Glossop, Gavin Whitlock, Karl Gibson
Chemical Communications (Cambridge, England)|November 5, 2003
Stereoselective synthesis of tetrahydropyran-3-ones by rearrangement of oxonium ylides generated from metal carbenoidsJ Stephen Clark, Gavin Whitlock, Shende Jiang, et al.
Drug Discovery Today|July 30, 2009
Understanding CYP2D6 interactionsMarcel J de Groot, Florian Wakenhut, Gavin Whitlock, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2009
Pharmacological properties of 2-((R-5-chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a novel and selective alpha1A-adrenergic partial agonist, in in vitro and in vivo models of urethral functionKelly Conlon, Clare Christy, Simon Westbrook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2026
A novel potent and selective GCN2 inhibitor, APL-4098, has anti-leukemic activity through dysregulation of mitochondrial functionMonica Román-Trufero, Gavin Whitlock, Claire Seydoux, et al.
Basic Research in Cardiology|May 21, 2021
Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?Maaike Te Lintel Hekkert, Gary Newton, Kathryn Chapman, et al.
Journal of Medicinal Chemistry|February 28, 2013
Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platformBimbisar Desai, Karen Dixon, Elizabeth Farrant, et al.
ACS Infectious Diseases|March 14, 2022
The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease OutbreaksKirandeep Samby, Dominique Besson, Anirban Dutta, et al.
Cell Chemical Biology|March 28, 2026
Reshaping the progranulin/sortilin interaction for targeted degradation of extracellular proteinsCamilla Gustafsen, Joachim Vilstrup, Marianne Kristensen, et al.
Pageof 1